Click here to download PDF Version of the final programme (1.8 MB)

Search through the abstracts in detail! Click here to start!

Click here to see photos from the conference!

HINT: to download photos from the album, look for the download icon in the bottom right corner

2011-1

About the Agenda Builder

The agenda builder is a simple, light-weight tool to manage your schedule. There are filters to narrow your search by day, track and/or presenter.

  • To use, simply click the "Add to my agenda" link. The  selected item will remain in memory indefinitely. 
  • Limitation: It will only "remember" the computer employed AND as long as you do not erase your "cookies".

>> Day 2 - Sunday, July 4, 2010

Print PDF
7:00 AM
Registration


Session 3: HPV vaccines

8:35 AM
Welcome & Opening Remarks

8:45 AM
How do HPV vaccines protect?
  Margaret Stanley, OBE, FMedSci, FRCOG
Professor, Department of Pathology, Christ's College, Cambridge, UK
9:00 AM
HPV vaccines: Trials and results
  0085_webJohn T. Schiller, PhD
Head, Neoplastic Disease Section, Senior Investigator, Laboratory of Cellular Oncology, National Cancer Institute, National Institutes of Health, Bethesda, USA
9:15 AM
Critical issues: Safety, duration of protection, cross-protection
9:30 AM
Vaccination in infants, males, immune-compromised and mid-adult women
  0037_webAnna R. Giuliano, PhD
Chair, Department of Cancer Epidemiology and Genetics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA
9:45 AM
Questions & Answers
10:00 AM
Break


Session 4: HIV and HPV
10:30 AM
HPV as risk factor for HIV
  0117_webSusan Cu-Uvin, MD
Professor, Obstetrics and Gynecology, Brown University, Providence, USA
10:45 AM
Burden of HPV disease in HIV infected individuals
11:00 AM
Anal cancer: how and when to screen?
11:15 AM
Questions & Answers
11:30 AM
Lunch


Session 5: Diseases related to non cancerous types

12:45 PM
The burden of low risk HPV
  0117_webSuzanne Garland, MD FRCP(C) MBBS
Director of Microbiological Research, Head of Clinical Microbiology and Infectious Diseases, Royal Women's Hospital, Melbourne, Australia

1:00 PM
External genital warts: diagnosis and treatment
 

0117_webMarc Steben, MD
Médecin conseil, Direction des risques biologiques et de la santé au travail, Institut national de santé publique du Québec, Montreal, Canada

1:15 PM
Laryngeal papillomatosis
0117_webPaolo Campisi, MSc, MD, FRCSC, FAAP
Associate Professor, Department of Otolaryngology – Head and Neck Surgery, University of Toronto, ,


Session 6: Strategic thinking in cancer prevention

1:30 PM
Cervical cancer prevention: using modeling to predict the optimal combinations of vaccination and screening

1:45 PM
Monitoring HPV vaccination campaigns
  0117_webMona Saraiya, MD, MPH
Medical Epidemiologist, CDC, Division of Cancer Prevention and Control

2:00 PM
Questions & Answers
2:15 PM
Break

2:45 PM
At the junction of biology and behavior: understanding and promoting HPV prevention
  0117_webWilliam A. Fisher
Distinguished University Professor, Departments of Psychology, Obstetrics and Gynaecology, University of Western Ontario, London, Canada

3:00 PM
Public health education and cervical cancer prevention

3:15 PM
WHO effort to control cervical cancer: from infection to palliative care

3:30 PM
World effort to bring HPV vaccine to developing countries

3:45 PM
Questions & Answers

4:00 PM
Closing comments
    Xavier Bosch, MD, PhD
Director, Research Program of Cancer Epidemiology, Catalan Oncology Institute (ICO)

Innovator_V2